2021 Volume 34 Issue 2 Pages 115-123
Based on the discovery of osseointegration, the JSOI has successfully developed and been committed to more sophisticated treatment methodologies and education thereon. Going forward, to gain further trust of patients, we need to acquire clinical evidence on the advantages and burden of oral implant treatment, which may lead to valid informed consent. In the near future, autologous bone transplantation may be minimized due to the availability of mesenchymal stem cells, biomaterials, and growth factors in a clinical setting. Peri-implantitis should be prevented and treated well. Problems in home care such as alveolar bone osteopenia and sclerosis as well as drug-related osteonecrosis of the jaw should be solved. It is possible that a biohybrid tooth root with periodontal tissue and tooth regeneration may be achieved. All of such innovations would support minimally invasive and maximally effective modalities in the future. It is hoped that these innovations will be produced within the JSOI.
